Can fecal calprotectin levels be used to monitor infant milk protein allergies?

Table 3 Comparison of growth and development of infants with a milk protein allergy before and after intervention (n = 90)

	Nonallergic group	Allergic group			*t	*p	^#t	^#p	^※t	^※p
	Nonallergic group	Before intervention	First visit	Second visit	*t	*p	^#t	^#p	^※t	^※p
WLZ (Mean ± SD)	0.365 ± 1.013	− 0.142 ± 1.091	− 0.102 ± 0.932	− 0.041 ± 0.831	− 0.881	0.380	− 1.897	0.061	− 1.899	0.061
WAZ (Mean ± SD)	0.315 ± 0.786	− 0.306 ± 1.171	− 0.187 ± 0.957	− 0.034 ± 0.852	− 1.837	0.070	− 3.323	0.001	− 3.759	< 0.001
LAZ (Mean ± SD)	0.135 ± 0.891	− 0.223 ± 1.216	0.108 ± 0.970	0.090 ± 0.921	− 1.164	0.248	− 2.598	0.011	− 3.023	0.003

p < 0.05 was considered significant
LAZ length-for-age Z-score, WAZ weight-for-age Z-score, WLZ weight-for-length Z-score
*Comparison between the first follow-up visit and before the intervention, ^#Comparison between the second follow-up visit and before the intervention, ^※Comparison between the second and the first visit

ISSN: 1710-1492